Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9CLB

Crystal structure of Bak bound to the inhibitory aBAK

9CLB の概要
エントリーDOI10.2210/pdb9clb/pdb
分子名称Bcl-2 homologous antagonist/killer, aBAK (2 entities in total)
機能のキーワードbak, inhibitor, bh3-mimetic, computational design, apoptosis
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数8
化学式量合計101523.04
構造登録者
主引用文献Berger, S.,Lee, E.F.,Harris, T.J.,Tran, S.,Bera, A.K.,Arguinchona, L.,Kang, A.,Sankaran, B.,Kasapgil, S.,Miller, M.S.,Smyth, S.,Lutfi, M.,Uren, R.T.,Kluck, R.M.,Colman, P.M.,Fairlie, W.D.,Czabotar, P.E.,Baker, D.,Birkinshaw, R.W.
Computational design of potent and selective binders of BAK and BAX.
Sci Adv, 11:eadt4170-eadt4170, 2025
Cited by
PubMed Abstract: Potent and selective binders of the key proapoptotic proteins BAK and BAX have not been described. We use computational protein design to generate high affinity binders of BAK and BAX with greater than 100-fold specificity for their target. Both binders activate their targets when at low concentration, driving pore formation, but inhibit membrane permeabilization when in excess. Crystallography shows that the BAK binder induces BAK unfolding, exposing the α6 helix and BH3 domain. Together, these data suggest that upon binding, BAK or BAX unfold; at high binder concentrations, self-association of the partially folded BAK or BAX proteins is blocked and the membrane remains intact, whereas at low concentrations, dimers form, and the membrane ruptures. Our designed binders modulate apoptosis via direct, specific interactions with BAK and BAX and reveal that for therapeutic strategies targeting BAK and BAX, inhibition requires saturating binder concentrations at the site of action.
PubMed: 40911686
DOI: 10.1126/sciadv.adt4170
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.86 Å)
構造検証レポート
Validation report summary of 9clb
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon